Cancer Chemoprevention by Cyclooxygenase 2 (COX-2) Blockade-Reference-Cited by-同舟云学术

Cancer Chemoprevention by Cyclooxygenase 2 (COX-2) Blockade

Published:2007 Issue: Volume: Page:193-212
ISSN:0306-0225
Container-title:Subcellular Biochemistry
language:
Short-container-title:

Author:

Harris Randall E.,Beebe-Donk Joanne,Alshafie Galal A.

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/1-4020-5688-5_9

Reference105 articles.

1. Ahmedin J, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer Statistics, 2006. CA Cancer J Clin 56 (2): 106–130, 2006.

2. Harris RE. COX-2 blockade in cancer prevention and therapy: widening the scope of impact. In: RE Harris (ed), COX-2 Blockade in Cancer Prevention and Therapy, pp 341–365, Humana Press, Totowa, NJ, 2002.

3. Harris RE, Beebe-Donk J, Doss H, Burr-Doss D. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncology Reports 13: 559–583, 2005.

4. Gonzalez-Perez A, Garcia Rodriquez LA, Lopez-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3: 1–12, 2003.

5. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 323–235, 1971.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity-dependent COX-2 proteolysis generates a catalytically inactive fragment that affects aerobic respiration and proliferation;2024-04-11

2. Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment;Frontiers in Pharmacology;2023-08-17

3. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors;Molecules;2023-01-20

4. Role of phospholipase A2 in squamous cell carcinoma and breast cancer;Phospholipases in Physiology and Pathology;2023

5. Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy—dual inhibition of COX-2 and 5-LOX enzymes;Medicinal Chemistry Research;2020-11-01